Inhibitors of phosphatidylinositol-3-kinase in cancer therapy

類似資料

• Take your PIK: PI-3-kinase inhibitors race through the clinic and towards cancer therapy
  著者:: Ihle, Nathan T., 等
  出版事項: (2009)
• Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
  著者:: Zhao, Wennan, 等
  出版事項: (2017)
• Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 while oncogenic Ras is a dominant predictor for resistance
  著者:: Ihle, NathanT., 等
  出版事項: (2009)
• The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling.
  著者:: Williams, Ryan, 等
  出版事項: (2006)
• Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
  著者:: Akinleye, Akintunde, 等
  出版事項: (2013)